Dr. Jerry Avorn is a professor of medicine at Harvard Medical School and chief of the Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women's Hospital in Boston. Stephen Morrissey, the interviewer, is the Managing Editor of the Journal. E. Colman and others. The FDA's Assessment of Two Drugs for Chronic Weight Management. N Engl J Med 2012;367:1577-9.